Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis

Abstract Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on...

Full description

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 64; no. 8; pp. 4525 - 4538
Main Authors Barde, François, Pacoureau, Lucas, Elbaz, Alexis, Seror, Raphaèle, Nguyen, Yann
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.08.2025
Oxford Publishing Limited (England)
Oxford University Press (OUP)
Subjects
Online AccessGet full text
ISSN1462-0324
1462-0332
1462-0332
DOI10.1093/rheumatology/keaf164

Cover

Abstract Abstract Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs. Results The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case–control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18–1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment).
AbstractList We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs. The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case-control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61-0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18-1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41-1.00). Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment).
We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and meta-analysis of observational studies.OBJECTIVESWe aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and meta-analysis of observational studies.Three databases (MEDLINE, EMBASE, WEB OF SCIENCE) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (OR) and their 95% confidence interval (CI).METHODSThree databases (MEDLINE, EMBASE, WEB OF SCIENCE) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (OR) and their 95% confidence interval (CI).The search strategy identified 4,210 references, of which 43 studies were analyzed and 17 were included in the meta-analysis (11 case-control studies, four cohort studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61-0.93) and whereas history of cardiovascular disease was positively associated with GCA with risk (OR = 1.28, 95% CI 1.18-1.38). We found a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41-1.00).RESULTSThe search strategy identified 4,210 references, of which 43 studies were analyzed and 17 were included in the meta-analysis (11 case-control studies, four cohort studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61-0.93) and whereas history of cardiovascular disease was positively associated with GCA with risk (OR = 1.28, 95% CI 1.18-1.38). We found a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41-1.00).Our study showed an inverse association of type 2 diabetes and a positive association of a history of cardiovascular disease with GCA risk. There is also a trend towards an inverse association with overweight. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors such as diet, or a condition following their diagnosis such as their treatment.CONCLUSIONOur study showed an inverse association of type 2 diabetes and a positive association of a history of cardiovascular disease with GCA risk. There is also a trend towards an inverse association with overweight. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors such as diet, or a condition following their diagnosis such as their treatment.
Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs. Results The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case–control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18–1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment).
Abstract Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs. Results The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case–control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18–1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment).
Abstract Objectives We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and meta-analysis of observational studies. Methods Three databases (MEDLINE, EMBASE, WEB OF SCIENCE) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (OR) and their 95% confidence interval (CI). Results The search strategy identified 4,210 references, of which 43 studies were analyzed and 17 were included in the meta-analysis (11 case-control studies, four cohort studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93) and whereas history of cardiovascular disease was positively associated with GCA with risk (OR = 1.28, 95% CI 1.18–1.38). We found a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association of type 2 diabetes and a positive association of a history of cardiovascular disease with GCA risk. There is also a trend towards an inverse association with overweight. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors such as diet, or a condition following their diagnosis such as their treatment.
Author Pacoureau, Lucas
Nguyen, Yann
Seror, Raphaèle
Barde, François
Elbaz, Alexis
Author_xml – sequence: 1
  givenname: François
  orcidid: 0000-0002-5652-225X
  surname: Barde
  fullname: Barde, François
– sequence: 2
  givenname: Lucas
  surname: Pacoureau
  fullname: Pacoureau, Lucas
– sequence: 3
  givenname: Alexis
  orcidid: 0000-0001-9724-5490
  surname: Elbaz
  fullname: Elbaz, Alexis
– sequence: 4
  givenname: Raphaèle
  surname: Seror
  fullname: Seror, Raphaèle
  email: Raphaele.seror@aphp.fr
– sequence: 5
  givenname: Yann
  orcidid: 0000-0002-0866-3824
  surname: Nguyen
  fullname: Nguyen, Yann
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40127188$$D View this record in MEDLINE/PubMed
https://hal.science/hal-05039673$$DView record in HAL
BookMark eNqN0U1r2zAYB3AxOtaX7RuMIdilO7iRLNmRdwulXQeBXbazeSw_atTaUibJKTn2m1dpsjB22kkP4vfXC_9zcuK8Q0I-cnbFWSNmYYXTCMkP_n47e0QwvJZvyBmXdVkwIcqT41zKU3Ie4wNjrOJCvSOnkvFyzpU6I8-LGL22kKx3tMP0hOiohtBbv4GopwECDTY-UgM6-RApuJ6mFVKv9RQCOp1HQ-8tuEQ1DgOFkDDYZONXCjRuY8L8SqtpwI3Fp9f8iAkKcDBso43vyVsDQ8QPh_WC_Lq9-Xl9Vyx_fPt-vVgWWtQsFVh2iGxupGqkkR2UzKBhQklpVI1V13GtBe-6su-AM6aqHrSpUfG-nNc11-KCfNmfu4KhXQc7Qti2Hmx7t1i2uz1WMdHUc7Hh2V7u7Tr43xPG1I427n4HDv0UW8EVa1T2KtPP_9AHP4X8t6xKUYlGCsmy-nRQUzdif7z_TxEZyD3QwccY0BwJZ-2u7_bvvttD3zk228f8tP6_xAt6IbUn
Cites_doi 10.1136/rmdopen-2020-001285
10.1093/rap/rkaa018
10.1093/rheumatology/keaa111.184
10.1007/s12026-013-8409-8
10.1056/NEJM198107093050216
10.1016/j.jacc.2003.12.047
10.3899/jrheum.121150
10.1093/rheumatology/keaa080
10.1097/WNO.0000000000000218
10.3390/jcm11102905
10.1136/rmdopen-2023-003493
10.3109/14397595.2015.1081722
10.1016/j.semarthrit.2020.05.003
10.7326/M12-3046
10.1016/j.semarthrit.2023.152298
10.1093/ije/18.4.836
10.1002/art.1780380311
10.1111/1756-185X.12631
10.3899/jrheum.220610
10.1136/annrheumdis-2013-204113
10.1016/j.jbspin.2018.05.011
10.1111/j.1756-185X.2010.01527.x
10.1093/rheumatology/keu331
10.1177/1937586717747384
10.3899/jrheum.140906
10.1093/rap/rky024
10.1136/ard.2009.111005
10.1002/art.1780330810
10.1016/j.ejim.2018.10.004
10.1016/j.semarthrit.2018.07.001
10.1093/rap/rkad095
10.1016/j.jaut.2009.12.003
10.1016/j.pharmthera.2020.107614
10.3109/03009742.2014.982701
10.7326/0003-4819-123-3-199508010-00006
10.1136/rmdopen-2022-002640
10.1016/j.phrs.2014.03.001
10.1002/art.24459
10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X
10.3390/ijms24010755
10.1080/03009742.2018.1506821
10.1016/j.semarthrit.2021.09.006
10.1002/acr.22416
10.1016/j.envint.2024.108602
ContentType Journal Article
Copyright The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2025
The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2025
– notice: The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
NAPCQ
7X8
1XC
DOI 10.1093/rheumatology/keaf164
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1462-0332
EndPage 4538
ExternalDocumentID oai_HAL_hal_05039673v1
40127188
10_1093_rheumatology_keaf164
10.1093/rheumatology/keaf164
Genre Meta-Analysis
Systematic Review
Journal Article
GrantInformation_xml – fundername: Fondation pour la Recherche Médicale
  grantid: FDM202306017277
GroupedDBID ---
-E4
.2P
.GJ
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29P
2WC
354
3O-
4.4
48X
53G
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAGKA
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNGD
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABVGC
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGKEF
AGORE
AGQPQ
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQDSO
ATGXG
ATTQO
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MHKGH
N9A
NGC
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBH
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RNI
ROL
ROX
RUSNO
RW1
RXO
RZF
RZO
SV3
TCURE
TEORI
TJX
TMA
TR2
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZGI
ZKX
ZY1
~91
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
NAPCQ
7X8
1XC
ID FETCH-LOGICAL-c360t-e2bee07f4894f4ba20fef03844f86e5bb1cc31bb2dba10085dacf6e81d27661c3
ISSN 1462-0324
1462-0332
IngestDate Fri Sep 12 12:40:37 EDT 2025
Thu Jul 10 19:30:53 EDT 2025
Mon Aug 04 10:10:37 EDT 2025
Wed Aug 06 16:36:22 EDT 2025
Thu Aug 07 06:02:03 EDT 2025
Mon Sep 15 00:05:45 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords giant cell arteritis
cardiovascular disease
smoking
meta-analysis
diabetes mellitus
cardiovascular risk factors
dyslipidemia
systematic review
hypertension
polymyalgia rheumatica
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
https://academic.oup.com/pages/standard-publication-reuse-rights
The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c360t-e2bee07f4894f4ba20fef03844f86e5bb1cc31bb2dba10085dacf6e81d27661c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5652-225X
0000-0001-9724-5490
0000-0002-0866-3824
0000-0002-5523-1856
PMID 40127188
PQID 3235394340
PQPubID 41027
PageCount 14
ParticipantIDs hal_primary_oai_HAL_hal_05039673v1
proquest_miscellaneous_3180985038
proquest_journals_3235394340
pubmed_primary_40127188
crossref_primary_10_1093_rheumatology_keaf164
oup_primary_10_1093_rheumatology_keaf164
PublicationCentury 2000
PublicationDate 2025-08-01
PublicationDateYYYYMMDD 2025-08-01
PublicationDate_xml – month: 08
  year: 2025
  text: 2025-08-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Rheumatology (Oxford, England)
PublicationTitleAlternate Rheumatology (Oxford)
PublicationYear 2025
Publisher Oxford University Press
Oxford Publishing Limited (England)
Oxford University Press (OUP)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
– name: Oxford University Press (OUP)
References Chandran (2025080115361602300_keaf164-B48) 2015; 44
Ungprasert (2025080115361602300_keaf164-B11) 2016; 19
Jakobsson (2025080115361602300_keaf164-B24) 2015; 54
Brennan (2025080115361602300_keaf164-B12) 2018; 48
Pugnet (2025080115361602300_keaf164-B27) 2015; 42
Kakafika (2025080115361602300_keaf164-B41) 2007; 71
Li (2025080115361602300_keaf164-B9) 2017; 56
Kang (2025080115361602300_keaf164-B17) 2022; 74
Salvarani (2025080115361602300_keaf164-B47) 1995; 123
Udayakumar (2025080115361602300_keaf164-B34) 2015; 67
Kermani (2025080115361602300_keaf164-B2) 2010; 69
Tomasson (2025080115361602300_keaf164-B3) 2014; 160
Nojima (2025080115361602300_keaf164-B54) 2023; 24
World Health Organization. Obesity (2025080115361602300_keaf164-B37)
Esen (2025080115361602300_keaf164-B23) 2023; 9
Ulivieri (2025080115361602300_keaf164-B52) 2014; 88
Greigert (2025080115361602300_keaf164-B5) 2022; 11
Arnson (2025080115361602300_keaf164-B39) 2010; 34
Garvey (2025080115361602300_keaf164-B45) 2021; 51
Dehnavi (2025080115361602300_keaf164-B53) 2020; 214
Singh (2025080115361602300_keaf164-B19) 2018; 2
Singh (2025080115361602300_keaf164-B30) 2019; 86
Moretti (2025080115361602300_keaf164-B42) 2024; 42
Chatzigeorgiou (2025080115361602300_keaf164-B21) 2023; 7
Hunder (2025080115361602300_keaf164-B13) 1990; 33
Elfishawi (2025080115361602300_keaf164-B8) 2023; 50
Turkiewicz (2025080115361602300_keaf164-B33) 2020; 6
Barde (2025080115361602300_keaf164-B50) 2024; 64
Ungprasert (2025080115361602300_keaf164-B10) 2016; 26
Caudrelier (2025080115361602300_keaf164-B49) 2019; 60
Gonzalez-Gay (2025080115361602300_keaf164-B1) 2009; 61
Pujades-Rodriguez (2025080115361602300_keaf164-B4) 2016; 102
Schmidt (2025080115361602300_keaf164-B29) 2013; 40
Higgins (2025080115361602300_keaf164-B14) 2024; 186
Spray (2025080115361602300_keaf164-B31) 2020; 59
Robson (2025080115361602300_keaf164-B28) 2015; 74
Feingold (2025080115361602300_keaf164-B44) 2000
Machado (2025080115361602300_keaf164-B25) 1989; 18
Duhaut (2025080115361602300_keaf164-B22) 1998; 41
Pati (2025080115361602300_keaf164-B15) 2018; 11
Mukhtyar (2025080115361602300_keaf164-B26) 2020; 4
Yates (2025080115361602300_keaf164-B36) 2017; 56
Barrier (2025080115361602300_keaf164-B6) 1981; 305
Ungprasert (2025080115361602300_keaf164-B43) 2015; 3
World Health Organization. Cardiovascular diseases (CVDs) (2025080115361602300_keaf164-B38)
Hoganson (2025080115361602300_keaf164-B16) 2010; 13
Partington (2025080115361602300_keaf164-B18) 2020; 50
Khattri (2025080115361602300_keaf164-B51) 2013; 56
Ambrose (2025080115361602300_keaf164-B40) 2004; 43
Abel (2025080115361602300_keaf164-B20) 2015; 35
Pacoureau (2025080115361602300_keaf164-B7) 2023; 9
Salvarani (2025080115361602300_keaf164-B46) 1995; 38
Wadström (2025080115361602300_keaf164-B35) 2020; 59
Tomasson (2025080115361602300_keaf164-B32) 2019; 48
References_xml – volume: 6
  start-page: e001285
  year: 2020
  ident: 2025080115361602300_keaf164-B33
  article-title: Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study
  publication-title: RMD Open.
  doi: 10.1136/rmdopen-2020-001285
– volume: 4
  start-page: rkaa018
  year: 2020
  ident: 2025080115361602300_keaf164-B26
  article-title: The relationship between glycated haemoglobin levels and the risk of giant cell arteritis—a case-control study
  publication-title: Rheumatol Adv Pract
  doi: 10.1093/rap/rkaa018
– ident: 2025080115361602300_keaf164-B37
– volume: 56
  start-page: 753
  year: 2017
  ident: 2025080115361602300_keaf164-B9
  article-title: Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink
  publication-title: Rheumatology
– volume: 59
  year: 2020
  ident: 2025080115361602300_keaf164-B31
  article-title: P189 Diabetes may confer protection from giant cell arteritis: results from a large inception cohort
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keaa111.184
– volume: 56
  start-page: 348
  year: 2013
  ident: 2025080115361602300_keaf164-B51
  article-title: Statins and autoimmunity
  publication-title: Immunol Res
  doi: 10.1007/s12026-013-8409-8
– volume: 305
  start-page: 104
  year: 1981
  ident: 2025080115361602300_keaf164-B6
  article-title: Increased prevalence of HLA-DR4 in giant-cell arteritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198107093050216
– volume: 43
  start-page: 1731
  year: 2004
  ident: 2025080115361602300_keaf164-B40
  article-title: The pathophysiology of cigarette smoking and cardiovascular disease: an update
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.12.047
– volume: 40
  start-page: 910
  year: 2013
  ident: 2025080115361602300_keaf164-B29
  article-title: Statin use in giant cell arteritis: a retrospective study
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.121150
– ident: 2025080115361602300_keaf164-B38
– volume: 59
  start-page: 3229
  year: 2020
  ident: 2025080115361602300_keaf164-B35
  article-title: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
  publication-title: Rheumatol Oxf Engl
  doi: 10.1093/rheumatology/keaa080
– volume: 35
  start-page: 134
  year: 2015
  ident: 2025080115361602300_keaf164-B20
  article-title: Effect of diabetes mellitus on giant cell arteritis
  publication-title: J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc
  doi: 10.1097/WNO.0000000000000218
– volume: 11
  start-page: 2905
  year: 2022
  ident: 2025080115361602300_keaf164-B5
  article-title: New insights into the pathogenesis of giant cell arteritis: mechanisms involved in maintaining vascular inflammation
  publication-title: J Clin Med
  doi: 10.3390/jcm11102905
– volume: 9
  start-page: e003493
  year: 2023
  ident: 2025080115361602300_keaf164-B7
  article-title: Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis
  publication-title: RMD Open.
  doi: 10.1136/rmdopen-2023-003493
– volume: 26
  start-page: 410
  year: 2016
  ident: 2025080115361602300_keaf164-B10
  article-title: Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: a systematic review and meta-analysis
  publication-title: Mod Rheumatol
  doi: 10.3109/14397595.2015.1081722
– volume: 50
  start-page: 663
  year: 2020
  ident: 2025080115361602300_keaf164-B18
  article-title: Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: a case control and cohort study
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2020.05.003
– volume: 42
  start-page: 1321
  year: 2024
  ident: 2025080115361602300_keaf164-B42
  article-title: The role of tobacco smoking in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review
  publication-title: Clin Exp Rheumatol
– volume: 160
  start-page: 73
  year: 2014
  ident: 2025080115361602300_keaf164-B3
  article-title: Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study
  publication-title: Ann Intern Med
  doi: 10.7326/M12-3046
– volume: 64
  start-page: 152298
  year: 2024
  ident: 2025080115361602300_keaf164-B50
  article-title: Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: a validation study
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2023.152298
– volume: 71
  start-page: 1173
  year: 2007
  ident: 2025080115361602300_keaf164-B41
  article-title: Smoking and aortic diseases
  publication-title: Circ J Off J Jpn Circ Soc
– volume: 18
  start-page: 836
  year: 1989
  ident: 2025080115361602300_keaf164-B25
  article-title: A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/18.4.836
– volume: 38
  start-page: 369
  year: 1995
  ident: 2025080115361602300_keaf164-B46
  article-title: Epidemiology of polymyalgia rheumatica in Olmsted county, Minnesota, 1970–1991
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780380311
– volume: 19
  start-page: 819
  year: 2016
  ident: 2025080115361602300_keaf164-B11
  article-title: Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.12631
– volume: 3
  start-page: 232
  year: 2015
  ident: 2025080115361602300_keaf164-B43
  article-title: Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis
  publication-title: Ann Transl Med
– volume: 50
  start-page: 526
  year: 2023
  ident: 2025080115361602300_keaf164-B8
  article-title: Lower frequency of comorbidities prior to onset of giant cell arteritis: a population-based study
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.220610
– volume: 74
  start-page: 129
  year: 2015
  ident: 2025080115361602300_keaf164-B28
  article-title: The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204113
– volume: 86
  start-page: 219
  year: 2019
  ident: 2025080115361602300_keaf164-B30
  article-title: The association of gout with incident giant cell arteritis in older adults
  publication-title: Joint Bone Spine
  doi: 10.1016/j.jbspin.2018.05.011
– volume: 13
  start-page: e1
  year: 2010
  ident: 2025080115361602300_keaf164-B16
  article-title: Lack of association of high body mass index with risk for developing polymyalgia rheumatica
  publication-title: Int J Rheum Dis
  doi: 10.1111/j.1756-185X.2010.01527.x
– volume: 54
  start-page: 433
  year: 2015
  ident: 2025080115361602300_keaf164-B24
  article-title: Body mass index and the risk of giant cell arteritis: results from a prospective study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu331
– volume: 74
  issue: Suppl 9
  year: 2022
  ident: 2025080115361602300_keaf164-B17
– volume: 11
  start-page: 15
  year: 2018
  ident: 2025080115361602300_keaf164-B15
  article-title: How to write a systematic review of the literature
  publication-title: HERD
  doi: 10.1177/1937586717747384
– volume: 42
  start-page: 316
  year: 2015
  ident: 2025080115361602300_keaf164-B27
  article-title: Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.140906
– volume: 2
  start-page: rky024
  year: 2018
  ident: 2025080115361602300_keaf164-B19
  article-title: The risk of polymyalgia rheumatica in older adults with gout: a Medicare claims study
  publication-title: Rheumatol Adv Pract
  doi: 10.1093/rap/rky024
– volume: 69
  start-page: 780
  year: 2010
  ident: 2025080115361602300_keaf164-B2
  article-title: Increase in age at onset of giant cell arteritis: a population-based study
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2009.111005
– volume: 33
  start-page: 1122
  year: 1990
  ident: 2025080115361602300_keaf164-B13
  article-title: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780330810
– volume: 60
  start-page: e16
  year: 2019
  ident: 2025080115361602300_keaf164-B49
  article-title: Validation of giant cell arteritis diagnosis code in the French hospital electronic database
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2018.10.004
– volume: 48
  start-page: 529
  year: 2018
  ident: 2025080115361602300_keaf164-B12
  article-title: Smoking as a risk factor for giant cell arteritis: a systematic review and meta-analysis
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2018.07.001
– volume: 7
  start-page: rkad095
  year: 2023
  ident: 2025080115361602300_keaf164-B21
  article-title: Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank
  publication-title: Rheumatol Adv Pract
  doi: 10.1093/rap/rkad095
– volume: 34
  start-page: J258
  year: 2010
  ident: 2025080115361602300_keaf164-B39
  article-title: Effects of tobacco smoke on immunity, inflammation and autoimmunity
  publication-title: J Autoimmun.
  doi: 10.1016/j.jaut.2009.12.003
– volume: 214
  start-page: 107614
  year: 2020
  ident: 2025080115361602300_keaf164-B53
  article-title: Statins and autoimmunity: state-of-the-art
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2020.107614
– volume-title: Endotext
  year: 2000
  ident: 2025080115361602300_keaf164-B44
– volume: 44
  start-page: 215
  year: 2015
  ident: 2025080115361602300_keaf164-B48
  article-title: The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009
  publication-title: Scand J Rheumatol
  doi: 10.3109/03009742.2014.982701
– volume: 123
  start-page: 192
  year: 1995
  ident: 2025080115361602300_keaf164-B47
  article-title: The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-123-3-199508010-00006
– volume: 9
  start-page: e002640
  year: 2023
  ident: 2025080115361602300_keaf164-B23
  article-title: Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort
  publication-title: RMD Open
  doi: 10.1136/rmdopen-2022-002640
– volume: 56
  start-page: 524
  year: 2017
  ident: 2025080115361602300_keaf164-B36
  article-title: The association of vascular risk factors with visual loss in giant cell arteritis
  publication-title: Rheumatology
– volume: 88
  start-page: 41
  year: 2014
  ident: 2025080115361602300_keaf164-B52
  article-title: Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2014.03.001
– volume: 61
  start-page: 1454
  year: 2009
  ident: 2025080115361602300_keaf164-B1
  article-title: Epidemiology of giant cell arteritis and polymyalgia rheumatica
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24459
– volume: 41
  start-page: 1960
  year: 1998
  ident: 2025080115361602300_keaf164-B22
  article-title: Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l’Artérite à Cellules Géantes
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X
– volume: 24
  start-page: 755
  year: 2023
  ident: 2025080115361602300_keaf164-B54
  article-title: Metformin and Its Immune-Mediated Effects in Various Diseases
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24010755
– volume: 48
  start-page: 213
  year: 2019
  ident: 2025080115361602300_keaf164-B32
  article-title: Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009742.2018.1506821
– volume: 102
  start-page: 383
  year: 2016
  ident: 2025080115361602300_keaf164-B4
  article-title: Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
  publication-title: Heart Br Card Soc
– volume: 51
  start-page: 1193
  year: 2021
  ident: 2025080115361602300_keaf164-B45
  article-title: Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2021.09.006
– volume: 67
  start-page: 396
  year: 2015
  ident: 2025080115361602300_keaf164-B34
  article-title: Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22416
– volume: 186
  start-page: 108602
  year: 2024
  ident: 2025080115361602300_keaf164-B14
  article-title: A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)
  publication-title: Environ Int
  doi: 10.1016/j.envint.2024.108602
SSID ssj0005138
Score 2.4747677
SecondaryResourceType review_article
Snippet Abstract Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis...
We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational...
Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of...
We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and...
Abstract Objectives We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic...
SourceID hal
proquest
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 4525
SubjectTerms Arteritis
Body weight
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - complications
Cardiovascular Diseases - epidemiology
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Dyslipidemia
Epidemiology
Giant Cell Arteritis - epidemiology
Giant Cell Arteritis - etiology
Heart Disease Risk Factors
Humans
Hypertension - epidemiology
Life Sciences
Meta-analysis
Obesity - epidemiology
Overweight
Risk Factors
Smoking - epidemiology
Systematic review
Title Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/40127188
https://www.proquest.com/docview/3235394340
https://www.proquest.com/docview/3180985038
https://hal.science/hal-05039673
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLW6ISFeEN90DGQQD0hTtiR2Upe3gTZVqAxpaqW-RY5jU4Ropi1FaG_8UX4L99pO6mwIDV6i1nWuXd8T58Y595iQ11VSwn1IxRHM_lnEtdKRMFkVyZHI4LrMMXcS2RYn-WTOPyyyxWDwK2AtrZtyX13-Ma_kf7wKZeBXzJL9B892RqEAPoN_4QgehuONfByMbUe4Un2CqaWOt5vqtGzJWikry6TsgsFnQEizhyv4e5bgiSpHLgf6qsyzYw9_042MpBczCYPb06VeQ22n6oQypj9a5rzfKiRYdngH3dRt5Gzf1o_qL118P8Wt2CC6VTWS5tcbgkkpL9u0nE1tmO_cosOpPFtKa0z4gfLrGWnWsemaME8yWITzmV7Y7yu9dVM2z9MoZi4Te1-HZaw3zzu1dI9nEUza-Go3CAB45vRmrt1cnPDWeTCW8PWrlibxpntq3iefiuP5dFrMjhazLXIrBdzbZPRFQEFK7E7r3T9oUzvH7CBs5cC30QudtpZI3O0lZV57NrIx0uweuesfbuihQ-p9MtCrB-T2R0_feEh-BoClHrC0D1iKgKUesBS8QAGwdANYWhtqAUsRsLQD7Fsq6Qau1MHVnt-D6yMyPz6avZ9Efg-QSLE8biKdllrHI8PFmBteyjQ22sRMcG5ErrOyTJRiSVmmVSlRpyqrpDK5hqcwHPBEscdke1Wv9FNCmZQsN7JSmnEu4FwwN8KTKmXGELIMSdQOb3HmpF4KR9FgReiOwrtjSF6BD7qqqNM-OZwWWIYiS-N8xL6D0Tfgohva2239WPhJ5qJgKcsYajjGQ_Ky-xluATjIcqXrNdRBDT6Buk5D8sT5v2uQI7UkEWLn78afkTuba3GXbDfna_0cou2mfGEh-xt_jN8s
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+cardiovascular+risk+factors+and+the+occurrence+of+giant+cell+arteritis%3A+a+systematic+review+and+meta-analysis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Barde%2C+Fran%C3%A7ois&rft.au=Lucas+Pacoureau&rft.au=Elbaz%2C+Alexis&rft.au=Seror%2C+Rapha%C3%A8le&rft.date=2025-08-01&rft.pub=Oxford+Publishing+Limited+%28England%29&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=64&rft.issue=8&rft.spage=4525&rft.epage=4538&rft_id=info:doi/10.1093%2Frheumatology%2Fkeaf164&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon